medullary carcinoma breast cancer

Release time ：Dec-26,2024

Medullary breast carcinoma is an uncommon form of breast cancer, distinguished by loosely packed tumor cells and a pronounced stromal response, which typically correlates with a more favorable prognosis.

Treatment for medullary breast carcinoma often encompasses a variety of modalities including surgery, radiation therapy, chemotherapy, and endocrine therapy. Surgical intervention is the primary treatment method, with common procedures being breast-conserving surgery and total mastectomy. Radiation therapy is primarily utilized to mitigate the risk of local recurrence, while chemotherapy targets potential micrometastatic foci. Endocrine therapy is predominantly indicated for patients with hormone receptor-positive tumors. The selection of a treatment regimen should be based on a comprehensive assessment of the patient’s condition, age, and tumor biology.

Patients diagnosed with medullary breast carcinoma are advised to undergo regular health check-ups and breast examinations to facilitate early detection and intervention. Additionally, it is crucial for patients to adhere to their physician’s recommendations, complete the prescribed treatment plan in a timely manner, and make lifestyle adjustments to maintain a positive outlook, thereby enhancing treatment efficacy and overall quality of life.